Swiss launch national database to track rare lung disease

NCT ID NCT03606200

First seen Dec 11, 2025 · Last updated May 13, 2026 · Updated 22 times

Summary

This study is creating a national registry in Switzerland for people diagnosed with Primary Ciliary Dyskinesia (PCD), a rare lung condition. Researchers will collect information on symptoms, treatments, and test results from up to 800 participants over time. The goal is to better understand the disease and support future research, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY CILIARY DYSKINESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Bern

    RECRUITING

    Bern, 3012, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.